Ignite Creation Date:
2024-05-06 @ 7:45 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02597868
Status:
UNKNOWN
Last Update Posted:
2016-03-29
First Post:
2014-03-09
Brief Title:
A Multicenter Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerOverstep
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Organization Data
Organization:
Zhejiang Cancer Hospital
Class:
OTHER
Study ID:
ZJCH15003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhejiang Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| 307 Hospital of PLA | OTHER |
| Fudan University | OTHER |
| The Tumor Hospital of Jiangsu Province | OTHER |
| Fujian Province Tumor Hospital | OTHER |
| Zhejiang University | OTHER |
| Sir Run Run Shaw Hospital | OTHER |
| Zhejiang Chinese Medical University | OTHER_GOV |
| Hangzhou Cancer Hospital | OTHER |
| Jiangsu Provincial Peoples Hospital | OTHER |